Efficacy and Safety of Prolonged Use of Eltrombopag and Romiplostim in Routine Clinical Practice in Patients with Chronic ITP.
Phase of Trial: Phase IV
Latest Information Update: 06 Sep 2016
At a glance
- Drugs Eltrombopag (Primary) ; Romiplostim (Primary)
- Indications Idiopathic thrombocytopenic purpura
- Focus Adverse reactions; Therapeutic Use
- 06 Sep 2016 New trial record